These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 13411428)
41. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078 [TBL] [Abstract][Full Text] [Related]
42. Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea. Hong YP; Jin BW; Kim SJ Aviat Space Environ Med; 1988 Feb; 59(2):185. PubMed ID: 3125824 [No Abstract] [Full Text] [Related]
43. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034 [TBL] [Abstract][Full Text] [Related]
45. Antimicrobially active concentrations of salizid and isoniazid in the blood. KASS I; MANDEL W; RUSSELL WF Am Rev Tuberc; 1956 Nov; 74(5):796-7. PubMed ID: 13372964 [No Abstract] [Full Text] [Related]
46. Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis. Molina-Moya B; Kazdaglis G; Lacoma A; Prat C; Gómez A; Villar-Hernández R; García-García E; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Domínguez J J Clin Microbiol; 2016 Apr; 54(4):1160-3. PubMed ID: 26865688 [TBL] [Abstract][Full Text] [Related]
47. The structure and function of the isoniazid target in M. tuberculosis. Sacchettini JC; Blanchard JS Res Microbiol; 1996; 147(1-2):36-43. PubMed ID: 8761720 [No Abstract] [Full Text] [Related]
48. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis. Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110 [TBL] [Abstract][Full Text] [Related]
49. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR. Hristea A; Otelea D; Paraschiv S; Macri A; Baicus C; Moldovan O; Tinischi M; Arama V; Streinu-Cercel A Indian J Med Microbiol; 2010; 28(3):211-6. PubMed ID: 20644308 [TBL] [Abstract][Full Text] [Related]
50. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. Seifert M; Catanzaro D; Catanzaro A; Rodwell TC PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046 [TBL] [Abstract][Full Text] [Related]
51. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania]. Placenti A Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375 [No Abstract] [Full Text] [Related]
52. [Factors affecting the activity of streptomycin, kanamycin and isoniazid in relation to intracellular Mycobacterium tuberculosis]. Pavlov EP Probl Tuberk; 1970; 48(9):72-6. PubMed ID: 4996496 [No Abstract] [Full Text] [Related]
53. [Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips]. Griadunov DA; Mikhaĭlovich VM; Lapa SA; Rudinskiĭ NI; Barskiĭ VE; Chudinov AV; Zasedatelev AS; Mirzabekov AD Mol Gen Mikrobiol Virusol; 2003; (4):24-7. PubMed ID: 14664159 [TBL] [Abstract][Full Text] [Related]
54. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155 [TBL] [Abstract][Full Text] [Related]
55. [Effect of kanamycin and isoniazid on the sensitivity of Mycobacterium tuberculosis to the defensive factors of the macroorganism]. Solov'ev VN; Sokolova EM; Chumachenko NV Probl Tuberk; 1965; 43(10):69-72. PubMed ID: 4959763 [No Abstract] [Full Text] [Related]
56. [Decreased catalase activity and virulence of isoniazid-resistant mycobacteriae]. SCHWEIGER O Tuberkulozis; 1958; 11(3-5):81-4. PubMed ID: 13581244 [No Abstract] [Full Text] [Related]
57. [Resistance determination in practice in a tuberculosis clinic]. ERMISCH K; ERMISCH U Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902 [No Abstract] [Full Text] [Related]
58. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762 [TBL] [Abstract][Full Text] [Related]
59. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Quémard A; Sacchettini JC; Dessen A; Vilcheze C; Bittman R; Jacobs WR; Blanchard JS Biochemistry; 1995 Jul; 34(26):8235-41. PubMed ID: 7599116 [TBL] [Abstract][Full Text] [Related]
60. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Wilson TM; Collins DM Mol Microbiol; 1996 Mar; 19(5):1025-34. PubMed ID: 8830260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]